LATIN AMERICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET ANALYSIS

Latin America Continuous Glucose Monitoring Device Market, by Component type (Transmitters, Receivers, Insulin Pump, and Sensors), by End User (Hospitals & Clinics, Retail Channel, and Online Channel), and by Country (Mexico, Argentina, Uruguay, Brazil, Colombia, Chile, Peru, and Rest of Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Sep 2022
Code : CMI2993
Pages :161
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Key Players

Major players are adopting inorganic growth strategies such as distribution agreement, in order to distribute their products in Latin America and increase their market share in the region. For instance, in February 2019, Senseonics Holdings, Inc., a medical technology company, announced expansion of distribution agreement with Roche Diabetes Care, a medical equipment supplying company, by providing them with exclusive distribution rights, for distribution of implantable continuous glucose monitoring (CGM) system, in 17 countries including Brazil, Russia, India, and China, as well as selected markets in the Asia Pacific and Latin American regions. Major players operating in the Latin America continuous glucose monitoring device market include Medtronic Plc., Abbott, F. Hoffmann-La Roche AG., Johnson & Johnson, Senseonics, Inc, Dexcom, Inc, Insulet Corporation, Tandem Diabetes Care, Inc, Roche Diagnositics, Lifescan, Bayer Health Care, AgaMatrixc Inc., Arkray Inc., and Nova Biomedical Corporation.